A detailed history of Qube Research & Technologies LTD transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 223,759 shares of RNA stock, worth $7.23 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
223,759
Holding current value
$7.23 Million
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$29.08 - $52.5 $6.51 Million - $11.7 Million
223,759 New
223,759 $6.51 Million
Q3 2023

Nov 13, 2023

BUY
$6.3 - $11.35 $295,123 - $531,690
46,845 Added 362.41%
59,771 $381,000
Q2 2023

Aug 14, 2023

BUY
$10.62 - $17.34 $137,274 - $224,136
12,926 New
12,926 $143,000
Q3 2022

Nov 14, 2022

BUY
$15.46 - $23.43 $460,058 - $697,229
29,758 New
29,758 $486,000

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $1.68B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.